简介：　　【摘 要】 目的：分析研究流行性感冒发病机制及预防措施效果。方法：本研究中的 90例流行性感冒患者于 2018年 01月至 2019年 01期间在本院进行就诊，以此作为本次的研究对象，应用 随机数字法对患者进行分组，分为参照组（患者数量 45例）和研究组（患者数量 45例）。其中给予传统常规治疗的为参照组，给予利巴韦林注射液治疗的为研究组，对两组的发烧头痛症状消失时间进行比较。结果：参照组患者发烧和头痛症状消失的时间显著长于研究组，有统计学意义（ P<0.05）。结论：应用在常规治疗的基础上应用利巴韦林注射液治疗的效果良好，发病机制主要是流感病毒所导致的，采取预防措施能够产生理想的效果，具有推广价值。  　　【关键词】 流行性感冒 ;发病机制 ;预防措施 ;效果  　　 [Abstract] Objective: to analyze the pathogenesis of influenza and the effect of preventive measures. Methods: 90 patients with influenza in this study were treated in our hospital from January 2018 to January 2019. As the study object, patients were divided into reference group (45 patients) and study group (45 patients) by random number method. Among them, the traditional conventional treatment group was the reference group, and the ribavirin injection group was the study group. Results: the disappearance time of fever and headache in the reference group was significantly longer than that in the study group (P < 0.05). Conclusion: the effect of ribavirin injection on the basis of routine treatment is good, the pathogenesis is mainly caused by influenza virus, and preventive measures can produce ideal effect, which is worth popularizing.

简介：　　【摘 要】目的：探讨流行性腮腺炎疾病的预防控制对策。方法：选取 210例流行性腮腺炎患者作为研究对象，对患者进行回顾性分析，统计患者的年龄分布情况、记录病症的临床表现、统计发病时间。结果：年龄≤ 6岁有 77例（ 36.7%），发病率最高， 7-12岁有 75例（ 35.7%）， 13-20岁和 >20岁的患者占比较低，年龄增长与流行性腮腺炎发病率呈反比。患者临床症状中，腮腺肿痛、发热是最常见的症状。发病时间集中在和 4-6月有 61例（ 29%），其次是 1-3月 58例（ 27.6%）； 2015年发病 89例（ 42.4%）， 2016年发病 78例（ 37.1%）， 2017年发病为 43例（ 20.5%），呈逐年递减趋势。结论：流行性腮腺炎疾病的预防控制应根据其发病年龄阶段、发病时间和临床特征进行针对性的预防控制，以控制传染源，阻断传播途径，以全面有效的控制疾病的流行发展。  　　【关键词】流行性腮腺炎；预防控制；对策   　 [Abstract] Objective: To explore the prevention and control of mumps. Methods: 210 patients with mumps were selected as the research object. The patients were analyzed retrospectively, and their age distribution, clinical manifestations and time of onset were recorded. Results: there were 77 cases (36.7%) with an age of less than 6 years old, the highest incidence rate, 75 cases (35.7%) at 7-12 years old, and 13-20 years old and >20 years old patients, which were inversely proportional to the incidence rate of mumps. Among the clinical symptoms, parotid gland swelling and fever are the most common symptoms. There were 61 cases (29%) from April to June, followed by 58 cases (27.6%) from January to March, 89 cases (42.4%) in 2015, 78 cases (37.1%) in 2016 and 43 cases (20.5%) in 2017, showing a decreasing trend year by year. Conclusion: the prevention and control of mumps should be carried out according to the age, time and clinical characteristics of the disease, so as to control the source of infection, block the route of transmission, and control the epidemic development of the disease comprehensively and effectively.